ReviewCell biochemistry and biophysics2026
EBV-Mediated Rewiring of ceRNA Networks in Nasopharyngeal Carcinoma: Mechanisms, ncRNA Interplay, and Oncogenic Implications.
Review in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Epstein-Barr virus (EBV) is a well-established oncogenic virus strongly associated with the development of nasopharyngeal carcinoma (NPC). Recent studies in transcriptomics have highlighted the crucial role of competing endogenous RNA (ceRNA) networks, including circular RNAs (circRNAs), microRNAs (miRNAs), and long non-coding RNA (lncRNA) in NPC progression. In particular, circRNAs act as miRNA sponges, preventing them from targeting specific mRNAs and thereby altering key oncogenic pathways. EBV employs multiple mechanisms to interfere with the host’s gene regulation, alters the expression of non-coding RNAs, and introduces its own viral RNAs. These changes disrupt tumor-suppressive ceRNA axes and establish oncogenic ceRNA networks, particularly those involved in immune evasion and cell cycle progression. Despite recent advances, the precise mechanisms by which EBV manipulates ceRNA networks remain underexplored. This review synthesizes these findings to propose a framework of patterns by which EBV systematically rewires the host ceRNA network, focusing on how EBV-encoded RNAs and host non-coding RNAs contribute to tumorigenesis.
Indexed as
Identifiers
41335294What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.